Canagliflozin

Overview

Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity. Source summary: Buy Canagliflozin to support advanced biochemical research; order now for reliable supply and unlock new possibilities in carbohydrate metabolism studies.

Application

Products > Drug Discovery > Impurities > Anti-Diabetic > Canagliflozin and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-461935
• CAS No.: 842133-18-0
• Molecular Formula: C24H25FO5S
• Molecular Weight: 444.52
• Purity: >98%
• Storage: Store at -20°C
• Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)

Source

Original product source